About Us

Pharmaceutical and biotechnology products
Home » About Us

Company Overview

Brighton Biotech (“BBI”) and Augment Pharmaceuticals, Inc. (“Augment”) merged in May 2015 to combine their pipelines and resources to form a new private biopharmaceutical company developing products in two indications of important unmet medical need.

BBI is closely affiliated with Pharmaceutical Regulatory Services, Inc. and PRS Clinical, Inc., two privately owned consulting firms that provide BBI cost and time effective usage of best development practices employed at large pharmaceutical companies, without the costly overhead.

BBI has big pharma capabilities without a big pharma infrastructure.